Gliknik Inc.

Industry · 2 registered clinical trials — 1 currently recruiting.

Status	Trial	Phase	Started
Recruiting	Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safet First in Man Study to Evaluate Initial Safety	Phase 1	2022-04-08
Completed	Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Squamous Cell Carcinoma of the Oral Cavity	Phase 2	2017-03-30